Prognostic values of left ventricular mass index progression in incident peritoneal dialysis patients : a prospective cohort study.

Yun Chen, Shuqi Dai, Xiaolin Ge, Da Shang, Qionghong Xie, Chuanming Hao, Tongying Zhu
Author Information
  1. Yun Chen: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  2. Shuqi Dai: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  3. Xiaolin Ge: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  4. Da Shang: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  5. Qionghong Xie: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  6. Chuanming Hao: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  7. Tongying Zhu: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China. zhuty@fudan.edu.cn.

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) is common among patients undergoing dialysis. However, the dynamic structural changes of LV are rarely discussed. The study aimed to investigate the prognostic significance of left ventricular mass index (LVMI)-progression in incident peritoneal dialysis (PD) patients, and explore risks factors for LVMI-progression.
METHODS: Incident PD patients between February 2008 and July 2018 were recruited. Echocardiography was performed yearly to collect LVMI and evaluate its changes. Participants were divided into three subgroups: group with LVMI-regression, group with LVMI stable and group with LVMI-progression. The end points include all-cause mortality, cardiovascular mortality and cardiovascular events. Cox regression models were performed to identify the associations between LVMI-progression and these endpoints. Multivariate logistic regression was conducted to identify risk factors for LVMI-progression.
RESULTS: A total of 216 PD patients (130 men,60.2%) with a mean age of 54.3 ± 16.8 years were recruited. LVMI-progression was identified in 72 patients (33.3%) after PD initiation. The cohort was followed for a median duration of 65.9 months. Multivariable Cox regression analysis revealed that LVMI-progression was an independent predictor of all-cause mortality (HR, 1.419; 95% CI, 1.016-1.982; p = 0.040), cardiovascular mortality (HR, 1.836; 95%CI, 1.084-3.108; p = 0.024), and cardiovascular events (HR, 1.494; 95%CI, 1.063-2.099; p = 0.021). Multivariable logistic regression showed that hemoglobin, ferritin, blood pressure and fibrinogen were significantly associated with LVMI-progression.
CONCLUSION: Early LVMI-progression was independently associated with all-cause mortality and cardiovascular outcomes in PD patients. The dynamic monitoring of LVMI might therefore help identify high-risk patients.

Keywords

References

  1. Ther Apher Dial. 2014 Jun;18(3):297-304 [PMID: 24965296]
  2. J Am Soc Echocardiogr. 2015 Jul;28(7):727-54 [PMID: 26140936]
  3. Am J Nephrol. 2014;39(2):92-9 [PMID: 24503489]
  4. Kidney Int. 2004 Apr;65(4):1492-8 [PMID: 15086493]
  5. Kidney Blood Press Res. 2012;35(6):431-7 [PMID: 22677801]
  6. Kidney Res Clin Pract. 2021 Mar;40(1):135-142 [PMID: 33789386]
  7. J Hum Hypertens. 2002 Aug;16(8):585-9 [PMID: 12149665]
  8. Clin Cardiol. 1992 Mar;15(3):190-6 [PMID: 1532353]
  9. Pediatr Nephrol. 2001 Apr;16(4):318-23 [PMID: 11354774]
  10. J Am Soc Nephrol. 2012 Oct;23(10):1725-34 [PMID: 22935481]
  11. Clin J Am Soc Nephrol. 2016 Feb 5;11(2):271-9 [PMID: 26668021]
  12. Pediatr Cardiol. 2010 Aug;31(6):821-8 [PMID: 20401476]
  13. Eur J Clin Invest. 2003 Jul;33(7):561-6 [PMID: 12814392]
  14. Int Urol Nephrol. 2014 Jun;46(6):1209-15 [PMID: 24307428]
  15. Cardiorenal Med. 2015 Feb;5(1):20-30 [PMID: 25759697]
  16. BMC Nephrol. 2021 Apr 16;22(1):135 [PMID: 33863299]
  17. J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S16-23 [PMID: 11443763]
  18. Nephrol Dial Transplant. 2021 Mar 29;36(4):665-672 [PMID: 31860093]
  19. Nephrol Dial Transplant. 2002;17 Suppl 1:29-36 [PMID: 11812909]
  20. Perit Dial Int. 2000 Jul-Aug;20(4):461-6 [PMID: 11007379]
  21. J Am Soc Nephrol. 2004 Aug;15(8):2186-94 [PMID: 15284304]
  22. Nephrol Dial Transplant. 1994;9(3):280-6 [PMID: 8052436]
  23. J Nephrol. 2022 Jan;35(1):233-244 [PMID: 34014512]
  24. J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S24-30 [PMID: 11443765]
  25. J Hypertens. 2009 Mar;27(3):633-41 [PMID: 19262231]
  26. Kidney Int. 2001 Aug;60(2):767-76 [PMID: 11473661]
  27. Am J Cardiol. 1986 Feb 15;57(6):450-8 [PMID: 2936235]
  28. J Hypertens. 2007 Sep;25(9):1751-62 [PMID: 17762635]

MeSH Term

Adult
Aged
Cohort Studies
Humans
Hypertrophy, Left Ventricular
Kidney Failure, Chronic
Male
Middle Aged
Peritoneal Dialysis
Prognosis
Prospective Studies
Renal Dialysis

Word Cloud

Created with Highcharts 10.0.0patientsLVMI-progression1PDmortalitycardiovascularventriculardialysisLVMIregressiongroupall-causeidentifyHRp = 0LefthypertrophydynamicchangesstudyleftmassindexincidentperitonealrisksfactorsrecruitedperformedeventsCoxlogisticcohortMultivariable95%CIassociatedBACKGROUND:LVHcommonamongundergoingHoweverstructuralLVrarelydiscussedaimedinvestigateprognosticsignificance-progressionexploreMETHODS:IncidentFebruary2008July2018EchocardiographyyearlycollectevaluateParticipantsdividedthreesubgroups:LVMI-regressionstableendpointsincludemodelsassociationsendpointsMultivariateconductedriskRESULTS:total216130men602%meanage543 ± 168 yearsidentified72333%initiationfollowedmedianduration659 monthsanalysisrevealedindependentpredictor41995%CI016-1982040836084-3108024494063-2099021showedhemoglobinferritinbloodpressurefibrinogensignificantlyCONCLUSION:Earlyindependentlyoutcomesmonitoringmightthereforehelphigh-riskPrognosticvaluesprogression:prospectiveCardiovascularPeritonealSurvival

Similar Articles

Cited By